Evidence map›Paper›PMID 26686632›Full record

ArticleCell reports2015

Stem Cell-Specific Mechanisms Ensure Genomic Fidelity within HSCs and upon Aging of HSCs.

Bettina M Moehrle, Kalpana Nattamai, Andreas Brown, Maria C Florian, Marnie Ryan, Mona Vogel, Corinna Bliederhaeuser, Karin Soller, Daniel R Prows, Amir Abdollahi and 6 more

Abstract read
In one paragraph

Article in Cell reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. The systemic costs of hematopoietic stem cell aging.Development (Cambridge, England) · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Mechanisms involved in hematopoietic stem cell aging.Cellular and molecular life sciences : CMLS · 2022
    Review
  9. Article
  10. Cellular enlargement - A new hallmark of aging?Frontiers in cell and developmental biology · 2022
    Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Bettina M MoehrleInstitute of Molecular Medicine, University of Ulm, 89081 Ulm, Germany.
Kalpana NattamaiDivision of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, OH 45229, USA.
Andreas BrownInstitute of Molecular Medicine, University of Ulm, 89081 Ulm, Germany.
Maria C FlorianInstitute of Molecular Medicine, University of Ulm, 89081 Ulm, Germany.
Marnie RyanDivision of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, OH 45229, USA.
Mona VogelInstitute of Molecular Medicine, University of Ulm, 89081 Ulm, Germany.
Corinna BliederhaeuserInstitute of Molecular Medicine, University of Ulm, 89081 Ulm, Germany.
Karin SollerInstitute of Molecular Medicine, University of Ulm, 89081 Ulm, Germany.
Daniel R ProwsDivision of Human Genetics, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, OH 45229, USA.
Amir AbdollahiGerman Cancer Consortium (DKTK), 69120 Heidelberg, Germany; Molecular and Translational Radiation Oncology, Heidelberg Ion Therapy Center (HIT), 69120 Heidelberg, Germany.
David SchleimerDivision of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, OH 45229, USA.
Dagmar WalterHeidelberg Institute for Stem Cell Technology and Experimental Medicine gGmbH (HI-STEM), 69120 Heidelberg, Germany.
Michael D MilsomHeidelberg Institute for Stem Cell Technology and Experimental Medicine gGmbH (HI-STEM), 69120 Heidelberg, Germany; Deutsches Krebsforschungszentrum (DKFZ), Division of Stem Cells and Cancer, Experimental Hematology Group, 69120 Heidelberg, Germany.
Peter StambrookDepartment of Molecular Genetics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
Matthew PorteusDepartment of Pediatrics, Stanford University, Stanford, CA 94305, USA.
Hartmut GeigerInstitute of Molecular Medicine, University of Ulm, 89081 Ulm, Germany; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, OH 45229, USA. Electronic address: hartmut.geiger@uni-ulm.de.

Funding

Lineage Determination and Tissue HomeOstasis in the aged Hematopoietic SystemR01AG040118 · NIA · CINCINNATI CHILDRENS HOSP MED CTR · PI GEIGER, HARTMUT, ZHENG, YI · 2011 to 2015
$1.7M
Genetic Reg. of Hematopoietic Stem Cell MobilizationR01HL076604 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI GEIGER, HARTMUT · 2004 to 2007
$1.2M
Young Stem Cell Potential in Aged MiceR21DK077762 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI GEIGER, HARTMUT · 2008 to 2009
$413k
NHLBI NIH HHS HL076604NHLBI NIH HHS R01 HL076604NIA NIH HHS AG040118NIA NIH HHS R01 AG040118NIDDK NIH HHS DK077762NIDDK NIH HHS R21 DK077762
6 · The paper itself

Abstract

Whether aged hematopoietic stem and progenitor cells (HSPCs) have impaired DNA damage repair is controversial. Using a combination of DNA mutation indicator assays, we observe a 2- to 3-fold increase in the number of DNA mutations in the hematopoietic system upon aging. Young and aged hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs) do not show an increase in mutation upon irradiation-induced DNA damage repair, and young and aged HSPCs respond very similarly to DNA damage with respect to cell-cycle checkpoint activation and apoptosis. Both young and aged HSPCs show impaired activation of the DNA-damage-induced G1-S checkpoint. Induction of chronic DNA double-strand breaks by zinc-finger nucleases suggests that HSPCs undergo apoptosis rather than faulty repair. These data reveal a protective mechanism in both the young and aged hematopoietic system against accumulation of mutations in response to DNA damage.

Indexed as

AgingGenomeAmino Acid SequenceAnimalsApoptosisBone Marrow CellsBone Marrow TransplantationCells, CulturedCheckpoint Kinase 2DNA DamageEndodeoxyribonucleasesG1 Phase Cell Cycle CheckpointsGamma RaysHematopoietic Stem CellsLoss of HeterozygosityMiceCheckpoint Kinase 2Chek2 protein, mouseEndodeoxyribonucleases

Identifiers

PMID26686632
PMCPMC4691560

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.